214 related articles for article (PubMed ID: 35941700)
21. Blue naevi and the blue tumour spectrum.
de la Fouchardiere A
Pathology; 2023 Mar; 55(2):187-195. PubMed ID: 36641378
[TBL] [Abstract][Full Text] [Related]
22. Uveal Melanoma:
Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
[TBL] [Abstract][Full Text] [Related]
23. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.
Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C
Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620
[TBL] [Abstract][Full Text] [Related]
24. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of the origin of an epibulbar melanocytic tumor with molecular genomics.
Gonzalez-H Leon A; Chavez Y; Kamil ZS; Ghazarian D; Krema H
Ophthalmic Genet; 2022 Aug; 43(4):518-521. PubMed ID: 35258412
[TBL] [Abstract][Full Text] [Related]
26. Research in practice: Therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma.
Gaffal E
J Dtsch Dermatol Ges; 2020 Nov; 18(11):1245-1248. PubMed ID: 32954611
[TBL] [Abstract][Full Text] [Related]
27. GNAQ
Urtatiz O; Cook C; Huang JL; Yeh I; Van Raamsdonk CD
Pigment Cell Melanoma Res; 2020 Jan; 33(1):96-111. PubMed ID: 31680437
[TBL] [Abstract][Full Text] [Related]
28. Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1.
Requena C; Traves V; Ferrandis E; Antón Almero M; García-Casado Z; Manrique-Silva E; Santos Briz Á; Escalonilla P; Nagore E
Actas Dermosifiliogr; 2023; 114(7):636-641. PubMed ID: 37088284
[TBL] [Abstract][Full Text] [Related]
29. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
Schöniger S; Summers BA
Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
[TBL] [Abstract][Full Text] [Related]
30. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
[TBL] [Abstract][Full Text] [Related]
31. GNA11-mutated and BAP1-negative Melanomas Ex Blue Naevi: A Particularly Aggressive Entity.
Uguen A; Guibourg B; Costa S; Marcorelles P
Acta Derm Venereol; 2017 Jun; 97(6):743-744. PubMed ID: 27990554
[No Abstract] [Full Text] [Related]
32. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.
Chan MP; Andea AA; Harms PW; Durham AB; Patel RM; Wang M; Robichaud P; Fisher GJ; Johnson TM; Fullen DR
Mod Pathol; 2016 Mar; 29(3):227-39. PubMed ID: 26743478
[TBL] [Abstract][Full Text] [Related]
33. The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.
Musi E; Ambrosini G; de Stanchina E; Schwartz GK
Mol Cancer Ther; 2014 May; 13(5):1044-53. PubMed ID: 24563540
[TBL] [Abstract][Full Text] [Related]
34. Superficial spreading melanoma and blue naevus within naevus spilus--ultrastructural assessment of giant pigment granules.
Cox NH; Malcolm A; Long ED
Dermatology; 1997; 194(3):213-6. PubMed ID: 9187835
[TBL] [Abstract][Full Text] [Related]
35. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
36. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.
Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE
Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
38. Taking the guesswork out of uveal melanoma.
Herlyn M; Nathanson KL
N Engl J Med; 2010 Dec; 363(23):2256-7. PubMed ID: 21083377
[No Abstract] [Full Text] [Related]
39. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
[TBL] [Abstract][Full Text] [Related]
40. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.
Daniels AB; Lee JE; MacConaill LE; Palescandolo E; Van Hummelen P; Adams SM; DeAngelis MM; Hahn WC; Gragoudas ES; Harbour JW; Garraway LA; Kim IK
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6991-6. PubMed ID: 22977135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
